Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Ejhaem|November 29, 2023
A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trialsLale Kostakoglu, Maurizio Martelli, Laurie H Sehn, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Haematologica|August 19, 2021
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA studyLale Kostakoglu, Federico Mattiello, Maurizio Martelli, et al.
Blood Advances|March 14, 2025
Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX studyBei Hu, Patrick M Reagan, Laurie H Sehn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2019
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with ImmunochemotherapyMagdalena Klanova, Mikkel Z Oestergaard, Marek Trněný, et al.
Blood Advances|March 2, 2021
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYALale Kostakoglu, Maurizio Martelli, Laurie H Sehn, et al.
Leukemia & Lymphoma|October 3, 2018
Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER studyJeff P Sharman, Andres Forero-Torres, Luciano J Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS StudyLaurie H Sehn, Andre Goy, Fritz C Offner, et al.
Pageof 7